Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | lamin | 0.0033 | 0.0186 | 0.0186 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0306 | 0.0288 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.2891 | 1 |
Echinococcus multilocularis | vesicular acetylcholine transporter | 0.0922 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0186 | 0.0186 |
Schistosoma mansoni | vesicular acetylcholine transporter | 0.0922 | 1 | 1 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0186 | 0.0186 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.0306 | 0.5 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.0306 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.0306 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0306 | 0.0306 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.0306 | 0.0306 |
Onchocerca volvulus | 0.0043 | 0.0306 | 0.0123 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0306 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0306 | 0.0306 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0186 | 0.0186 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0186 | 0.0186 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.0306 | 0.0306 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0306 | 0.0123 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0306 | 0.0288 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.0306 | 0.5 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.0306 | 0.0306 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0179 | 0.0179 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0186 | 0.0167 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0186 | 0.0186 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.0306 | 0.5 |
Trichomonas vaginalis | esterase, putative | 0.0043 | 0.0306 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0306 | 0.0306 |
Brugia malayi | beta-lactamase | 0.0043 | 0.0306 | 0.0288 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0186 | 0.0186 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0306 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0306 | 0.0306 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.0019 | 0.0019 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0186 | 0.0186 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.0306 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0306 | 0.5 |
Onchocerca volvulus | 0.0043 | 0.0306 | 0.0123 | |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0306 | 0.0123 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0306 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.0306 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.0306 | 0.5 |
Echinococcus granulosus | vesicular acetylcholine transporter | 0.0922 | 1 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.0306 | 0.5 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.0306 | 0.0288 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.0306 | 0.5 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | 0.0922 | 1 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.0306 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0306 | 0.5 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | 0.0922 | 1 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0186 | 0.0186 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0306 | 0.0306 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.0306 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0186 | 0.0167 |
Onchocerca volvulus | 0.0043 | 0.0306 | 0.0123 | |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.0306 | 0.0306 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0306 | 0.0306 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.0306 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.3162 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.